 | • レポートコード：QYR2104Z1539 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、うっ血性心不全（CHF）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、カプセル、錠剤）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・うっ血性心不全（CHF）の市場動向 ・企業の競争状況、市場シェア ・うっ血性心不全（CHF）の種類別市場規模（注射、カプセル、錠剤） ・うっ血性心不全（CHF）の用途別市場規模（病院、クリニック） ・うっ血性心不全（CHF）の北米市場規模2016-2027（アメリカ、カナダ） ・うっ血性心不全（CHF）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・うっ血性心不全（CHF）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・うっ血性心不全（CHF）の中南米市場規模2016-2027（メキシコ、ブラジル） ・うっ血性心不全（CHF）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Novartis、Pfizer、Merck & Co、AstraZeneca、GSK、Bristol-Myers Squibb、Mylan、Bausch Health、Johnson & Johnson、Bayer、Boehringer Inhelheim、Exelixis、Lunan Pharmaceutical、Sinepharm、CRC、Hai Ni Pharmaceutical、Langtian、NCPC、Hayao、Xinhua Group、Xudong Haipu Pharmaceutical） ・結論 |
Market Analysis and Insights: Global Congestive Heart Failure (CHF) Market
The global Congestive Heart Failure (CHF) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Congestive Heart Failure (CHF) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Congestive Heart Failure (CHF) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Congestive Heart Failure (CHF) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Congestive Heart Failure (CHF) market.
Global Congestive Heart Failure (CHF) Scope and Market Size
Congestive Heart Failure (CHF) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Congestive Heart Failure (CHF) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Capsule
Tablets
Segment by Application
Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi
Novartis
Pfizer
Merck & Co
AstraZeneca
GSK
Bristol-Myers Squibb
Mylan
Bausch Health
Merck & Co
AstraZeneca
Boehringer Inhelheim
Exelixis
Lunan Pharmaceutical
Sinepharm
CRC
Hai Ni Pharmaceutical
Langtian
NCPC
Hayao
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Congestive Heart Failure (CHF) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Capsule
1.2.4 Tablets
1.3 Market by Application
1.3.1 Global Congestive Heart Failure (CHF) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Congestive Heart Failure (CHF) Market Perspective (2016-2027)
2.2 Congestive Heart Failure (CHF) Growth Trends by Regions
2.2.1 Congestive Heart Failure (CHF) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Congestive Heart Failure (CHF) Historic Market Share by Regions (2016-2021)
2.2.3 Congestive Heart Failure (CHF) Forecasted Market Size by Regions (2022-2027)
2.3 Congestive Heart Failure (CHF) Industry Dynamic
2.3.1 Congestive Heart Failure (CHF) Market Trends
2.3.2 Congestive Heart Failure (CHF) Market Drivers
2.3.3 Congestive Heart Failure (CHF) Market Challenges
2.3.4 Congestive Heart Failure (CHF) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Congestive Heart Failure (CHF) Players by Revenue
3.1.1 Global Top Congestive Heart Failure (CHF) Players by Revenue (2016-2021)
3.1.2 Global Congestive Heart Failure (CHF) Revenue Market Share by Players (2016-2021)
3.2 Global Congestive Heart Failure (CHF) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Congestive Heart Failure (CHF) Revenue
3.4 Global Congestive Heart Failure (CHF) Market Concentration Ratio
3.4.1 Global Congestive Heart Failure (CHF) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Congestive Heart Failure (CHF) Revenue in 2020
3.5 Congestive Heart Failure (CHF) Key Players Head office and Area Served
3.6 Key Players Congestive Heart Failure (CHF) Product Solution and Service
3.7 Date of Enter into Congestive Heart Failure (CHF) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Congestive Heart Failure (CHF) Breakdown Data by Type
4.1 Global Congestive Heart Failure (CHF) Historic Market Size by Type (2016-2021)
4.2 Global Congestive Heart Failure (CHF) Forecasted Market Size by Type (2022-2027)
5 Congestive Heart Failure (CHF) Breakdown Data by Application
5.1 Global Congestive Heart Failure (CHF) Historic Market Size by Application (2016-2021)
5.2 Global Congestive Heart Failure (CHF) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Congestive Heart Failure (CHF) Market Size (2016-2027)
6.2 North America Congestive Heart Failure (CHF) Market Size by Type
6.2.1 North America Congestive Heart Failure (CHF) Market Size by Type (2016-2021)
6.2.2 North America Congestive Heart Failure (CHF) Market Size by Type (2022-2027)
6.2.3 North America Congestive Heart Failure (CHF) Market Size by Type (2016-2027)
6.3 North America Congestive Heart Failure (CHF) Market Size by Application
6.3.1 North America Congestive Heart Failure (CHF) Market Size by Application (2016-2021)
6.3.2 North America Congestive Heart Failure (CHF) Market Size by Application (2022-2027)
6.3.3 North America Congestive Heart Failure (CHF) Market Size by Application (2016-2027)
6.4 North America Congestive Heart Failure (CHF) Market Size by Country
6.4.1 North America Congestive Heart Failure (CHF) Market Size by Country (2016-2021)
6.4.2 North America Congestive Heart Failure (CHF) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Congestive Heart Failure (CHF) Market Size (2016-2027)
7.2 Europe Congestive Heart Failure (CHF) Market Size by Type
7.2.1 Europe Congestive Heart Failure (CHF) Market Size by Type (2016-2021)
7.2.2 Europe Congestive Heart Failure (CHF) Market Size by Type (2022-2027)
7.2.3 Europe Congestive Heart Failure (CHF) Market Size by Type (2016-2027)
7.3 Europe Congestive Heart Failure (CHF) Market Size by Application
7.3.1 Europe Congestive Heart Failure (CHF) Market Size by Application (2016-2021)
7.3.2 Europe Congestive Heart Failure (CHF) Market Size by Application (2022-2027)
7.3.3 Europe Congestive Heart Failure (CHF) Market Size by Application (2016-2027)
7.4 Europe Congestive Heart Failure (CHF) Market Size by Country
7.4.1 Europe Congestive Heart Failure (CHF) Market Size by Country (2016-2021)
7.4.2 Europe Congestive Heart Failure (CHF) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Congestive Heart Failure (CHF) Market Size (2016-2027)
8.2 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type
8.2.1 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type (2016-2027)
8.3 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application
8.3.1 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application (2016-2027)
8.4 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region
8.4.1 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Congestive Heart Failure (CHF) Market Size (2016-2027)
9.2 Latin America Congestive Heart Failure (CHF) Market Size by Type
9.2.1 Latin America Congestive Heart Failure (CHF) Market Size by Type (2016-2021)
9.2.2 Latin America Congestive Heart Failure (CHF) Market Size by Type (2022-2027)
9.2.3 Latin America Congestive Heart Failure (CHF) Market Size by Type (2016-2027)
9.3 Latin America Congestive Heart Failure (CHF) Market Size by Application
9.3.1 Latin America Congestive Heart Failure (CHF) Market Size by Application (2016-2021)
9.3.2 Latin America Congestive Heart Failure (CHF) Market Size by Application (2022-2027)
9.3.3 Latin America Congestive Heart Failure (CHF) Market Size by Application (2016-2027)
9.4 Latin America Congestive Heart Failure (CHF) Market Size by Country
9.4.1 Latin America Congestive Heart Failure (CHF) Market Size by Country (2016-2021)
9.4.2 Latin America Congestive Heart Failure (CHF) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Congestive Heart Failure (CHF) Market Size (2016-2027)
10.2 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type
10.2.1 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type (2016-2027)
10.3 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application
10.3.1 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application (2016-2027)
10.4 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country
10.4.1 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Congestive Heart Failure (CHF) Introduction
11.1.4 Sanofi Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Congestive Heart Failure (CHF) Introduction
11.2.4 Novartis Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Congestive Heart Failure (CHF) Introduction
11.3.4 Pfizer Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Details
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Congestive Heart Failure (CHF) Introduction
11.4.4 Merck & Co Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.4.5 Merck & Co Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Congestive Heart Failure (CHF) Introduction
11.5.4 AstraZeneca Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 GSK
11.6.1 GSK Company Details
11.6.2 GSK Business Overview
11.6.3 GSK Congestive Heart Failure (CHF) Introduction
11.6.4 GSK Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.6.5 GSK Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Congestive Heart Failure (CHF) Introduction
11.7.4 Bristol-Myers Squibb Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Congestive Heart Failure (CHF) Introduction
11.8.4 Mylan Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Bausch Health
11.9.1 Bausch Health Company Details
11.9.2 Bausch Health Business Overview
11.9.3 Bausch Health Congestive Heart Failure (CHF) Introduction
11.9.4 Bausch Health Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.9.5 Bausch Health Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Congestive Heart Failure (CHF) Introduction
11.10.4 Johnson & Johnson Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Bayer
11.11.1 Bayer Company Details
11.11.2 Bayer Business Overview
11.11.3 Bayer Congestive Heart Failure (CHF) Introduction
11.11.4 Bayer Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.11.5 Bayer Recent Development
11.12 Boehringer Inhelheim
11.12.1 Boehringer Inhelheim Company Details
11.12.2 Boehringer Inhelheim Business Overview
11.12.3 Boehringer Inhelheim Congestive Heart Failure (CHF) Introduction
11.12.4 Boehringer Inhelheim Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.12.5 Boehringer Inhelheim Recent Development
11.13 Exelixis
11.13.1 Exelixis Company Details
11.13.2 Exelixis Business Overview
11.13.3 Exelixis Congestive Heart Failure (CHF) Introduction
11.13.4 Exelixis Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.13.5 Exelixis Recent Development
11.14 Lunan Pharmaceutical
11.14.1 Lunan Pharmaceutical Company Details
11.14.2 Lunan Pharmaceutical Business Overview
11.14.3 Lunan Pharmaceutical Congestive Heart Failure (CHF) Introduction
11.14.4 Lunan Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.14.5 Lunan Pharmaceutical Recent Development
11.15 Sinepharm
11.15.1 Sinepharm Company Details
11.15.2 Sinepharm Business Overview
11.15.3 Sinepharm Congestive Heart Failure (CHF) Introduction
11.15.4 Sinepharm Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.15.5 Sinepharm Recent Development
11.16 CRC
11.16.1 CRC Company Details
11.16.2 CRC Business Overview
11.16.3 CRC Congestive Heart Failure (CHF) Introduction
11.16.4 CRC Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.16.5 CRC Recent Development
11.17 Hai Ni Pharmaceutical
11.17.1 Hai Ni Pharmaceutical Company Details
11.17.2 Hai Ni Pharmaceutical Business Overview
11.17.3 Hai Ni Pharmaceutical Congestive Heart Failure (CHF) Introduction
11.17.4 Hai Ni Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.17.5 Hai Ni Pharmaceutical Recent Development
11.18 Langtian
11.18.1 Langtian Company Details
11.18.2 Langtian Business Overview
11.18.3 Langtian Congestive Heart Failure (CHF) Introduction
11.18.4 Langtian Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.18.5 Langtian Recent Development
11.18 NCPC
.1 NCPC Company Details
.2 NCPC Business Overview
.3 NCPC Congestive Heart Failure (CHF) Introduction
.4 NCPC Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
.5 NCPC Recent Development
11.20 Hayao
11.20.1 Hayao Company Details
11.20.2 Hayao Business Overview
11.20.3 Hayao Congestive Heart Failure (CHF) Introduction
11.20.4 Hayao Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.20.5 Hayao Recent Development
11.21 Xinhua Group
11.21.1 Xinhua Group Company Details
11.21.2 Xinhua Group Business Overview
11.21.3 Xinhua Group Congestive Heart Failure (CHF) Introduction
11.21.4 Xinhua Group Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.21.5 Xinhua Group Recent Development
11.22 Xudong Haipu Pharmaceutical
11.22.1 Xudong Haipu Pharmaceutical Company Details
11.22.2 Xudong Haipu Pharmaceutical Business Overview
11.22.3 Xudong Haipu Pharmaceutical Congestive Heart Failure (CHF) Introduction
11.22.4 Xudong Haipu Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021)
11.22.5 Xudong Haipu Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Congestive Heart Failure (CHF) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Capsule
Table 4. Key Players of Tablets
Table 5. Global Congestive Heart Failure (CHF) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Congestive Heart Failure (CHF) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Congestive Heart Failure (CHF) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Congestive Heart Failure (CHF) Market Share by Regions (2016-2021)
Table 9. Global Congestive Heart Failure (CHF) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Congestive Heart Failure (CHF) Market Share by Regions (2022-2027)
Table 11. Congestive Heart Failure (CHF) Market Trends
Table 12. Congestive Heart Failure (CHF) Market Drivers
Table 13. Congestive Heart Failure (CHF) Market Challenges
Table 14. Congestive Heart Failure (CHF) Market Restraints
Table 15. Global Congestive Heart Failure (CHF) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Congestive Heart Failure (CHF) Market Share by Players (2016-2021)
Table 17. Global Top Congestive Heart Failure (CHF) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congestive Heart Failure (CHF) as of 2020)
Table 18. Ranking of Global Top Congestive Heart Failure (CHF) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Congestive Heart Failure (CHF) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Congestive Heart Failure (CHF) Product Solution and Service
Table 22. Date of Enter into Congestive Heart Failure (CHF) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Congestive Heart Failure (CHF) Revenue Market Share by Type (2016-2021)
Table 26. Global Congestive Heart Failure (CHF) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Congestive Heart Failure (CHF) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Congestive Heart Failure (CHF) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Congestive Heart Failure (CHF) Revenue Market Share by Application (2016-2021)
Table 30. Global Congestive Heart Failure (CHF) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Congestive Heart Failure (CHF) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Congestive Heart Failure (CHF) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Congestive Heart Failure (CHF) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Congestive Heart Failure (CHF) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Congestive Heart Failure (CHF) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Congestive Heart Failure (CHF) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Congestive Heart Failure (CHF) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Congestive Heart Failure (CHF) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Congestive Heart Failure (CHF) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Congestive Heart Failure (CHF) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Congestive Heart Failure (CHF) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Congestive Heart Failure (CHF) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Congestive Heart Failure (CHF) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Congestive Heart Failure (CHF) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Congestive Heart Failure (CHF) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Congestive Heart Failure (CHF) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Congestive Heart Failure (CHF) Product
Table 65. Sanofi Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Congestive Heart Failure (CHF) Product
Table 70. Novartis Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Congestive Heart Failure (CHF) Product
Table 75. Pfizer Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Merck & Co Company Details
Table 78. Merck & Co Business Overview
Table 79. Merck & Co Congestive Heart Failure (CHF) Product
Table 80. Merck & Co Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 81. Merck & Co Recent Development
Table 82. AstraZeneca Company Details
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Congestive Heart Failure (CHF) Product
Table 85. AstraZeneca Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 86. AstraZeneca Recent Development
Table 87. GSK Company Details
Table 88. GSK Business Overview
Table 89. GSK Congestive Heart Failure (CHF) Product
Table 90. GSK Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 91. GSK Recent Development
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Congestive Heart Failure (CHF) Product
Table 95. Bristol-Myers Squibb Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Mylan Company Details
Table 98. Mylan Business Overview
Table 99. Mylan Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 100. Mylan Recent Development
Table 101. Bausch Health Company Details
Table 102. Bausch Health Business Overview
Table 103. Bausch Health Congestive Heart Failure (CHF) Product
Table 104. Bausch Health Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 105. Bausch Health Recent Development
Table 106. Johnson & Johnson Company Details
Table 107. Johnson & Johnson Business Overview
Table 108. Johnson & Johnson Congestive Heart Failure (CHF) Product
Table 109. Johnson & Johnson Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 110. Johnson & Johnson Recent Development
Table 111. Bayer Company Details
Table 112. Bayer Business Overview
Table 113. Bayer Congestive Heart Failure (CHF) Product
Table 114. Bayer Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 115. Bayer Recent Development
Table 116. Boehringer Inhelheim Company Details
Table 117. Boehringer Inhelheim Business Overview
Table 118. Boehringer Inhelheim Congestive Heart Failure (CHF) Product
Table 119. Boehringer Inhelheim Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 120. Boehringer Inhelheim Recent Development
Table 121. Exelixis Company Details
Table 122. Exelixis Business Overview
Table 123. Exelixis Congestive Heart Failure (CHF) Product
Table 124. Exelixis Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 125. Exelixis Recent Development
Table 126. Lunan Pharmaceutical Company Details
Table 127. Lunan Pharmaceutical Business Overview
Table 128. Lunan Pharmaceutical Congestive Heart Failure (CHF) Product
Table 129. Lunan Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 130. Lunan Pharmaceutical Recent Development
Table 131. Sinepharm Company Details
Table 132. Sinepharm Business Overview
Table 133. Sinepharm Congestive Heart Failure (CHF) Product
Table 134. Sinepharm Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 135. Sinepharm Recent Development
Table 136. CRC Company Details
Table 137. CRC Business Overview
Table 138. CRC Congestive Heart Failure (CHF) Product
Table 139. CRC Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 140. CRC Recent Development
Table 141. Hai Ni Pharmaceutical Company Details
Table 142. Hai Ni Pharmaceutical Business Overview
Table 143. Hai Ni Pharmaceutical Congestive Heart Failure (CHF) Product
Table 144. Hai Ni Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 145. Hai Ni Pharmaceutical Recent Development
Table 146. Langtian Company Details
Table 147. Langtian Business Overview
Table 148. Langtian Congestive Heart Failure (CHF) Product
Table 149. Langtian Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 150. Langtian Recent Development
Table 151. NCPC Company Details
Table 152. NCPC Business Overview
Table 153. NCPC Congestive Heart Failure (CHF) Product
Table 154. NCPC Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 155. NCPC Recent Development
Table 156. Hayao Company Details
Table 157. Hayao Business Overview
Table 158. Hayao Congestive Heart Failure (CHF) Product
Table 159. Hayao Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 160. Hayao Recent Development
Table 161. Xinhua Group Company Details
Table 162. Xinhua Group Business Overview
Table 163. Xinhua Group Congestive Heart Failure (CHF) Product
Table 164. Xinhua Group Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 165. Xinhua Group Recent Development
Table 166. Xudong Haipu Pharmaceutical Company Details
Table 167. Xudong Haipu Pharmaceutical Business Overview
Table 168. Xudong Haipu Pharmaceutical Congestive Heart Failure (CHF) Product
Table 169. Xudong Haipu Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million)
Table 170. Xudong Haipu Pharmaceutical Recent Development
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Congestive Heart Failure (CHF) Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Capsule Features
Figure 4. Tablets Features
Figure 5. Global Congestive Heart Failure (CHF) Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Congestive Heart Failure (CHF) Report Years Considered
Figure 9. Global Congestive Heart Failure (CHF) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Congestive Heart Failure (CHF) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Congestive Heart Failure (CHF) Market Share by Regions: 2020 VS 2027
Figure 12. Global Congestive Heart Failure (CHF) Market Share by Regions (2022-2027)
Figure 13. Global Congestive Heart Failure (CHF) Market Share by Players in 2020
Figure 14. Global Top Congestive Heart Failure (CHF) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congestive Heart Failure (CHF) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Congestive Heart Failure (CHF) Revenue in 2020
Figure 16. Global Congestive Heart Failure (CHF) Revenue Market Share by Type (2016-2021)
Figure 17. Global Congestive Heart Failure (CHF) Revenue Market Share by Type (2022-2027)
Figure 18. North America Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Congestive Heart Failure (CHF) Market Share by Type (2016-2027)
Figure 20. North America Congestive Heart Failure (CHF) Market Share by Application (2016-2027)
Figure 21. North America Congestive Heart Failure (CHF) Market Share by Country (2016-2027)
Figure 22. United States Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Congestive Heart Failure (CHF) Market Share by Type (2016-2027)
Figure 26. Europe Congestive Heart Failure (CHF) Market Share by Application (2016-2027)
Figure 27. Europe Congestive Heart Failure (CHF) Market Share by Country (2016-2027)
Figure 28. Germany Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Congestive Heart Failure (CHF) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Congestive Heart Failure (CHF) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Congestive Heart Failure (CHF) Market Share by Region (2016-2027)
Figure 38. China Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Congestive Heart Failure (CHF) Market Share by Type (2016-2027)
Figure 46. Latin America Congestive Heart Failure (CHF) Market Share by Application (2016-2027)
Figure 47. Latin America Congestive Heart Failure (CHF) Market Share by Country (2016-2027)
Figure 48. Mexico Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Congestive Heart Failure (CHF) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Congestive Heart Failure (CHF) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Congestive Heart Failure (CHF) Market Share by Country (2016-2027)
Figure 54. Turkey Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Sanofi Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 60. Merck & Co Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 65. Bausch Health Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 66. Johnson & Johnson Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 68. Boehringer Inhelheim Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 69. Exelixis Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 70. Lunan Pharmaceutical Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 71. Sinepharm Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 72. CRC Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 73. Hai Ni Pharmaceutical Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 74. Langtian Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 75. NCPC Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 76. Hayao Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 77. Xinhua Group Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 78. Xudong Haipu Pharmaceutical Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界のうっ血性心不全用治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Medicines for Congestive Heart Failure Market The global Medicines for Congestive Heart Failure market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…- 世界のうっ血性心不全（CHF）治療用装置市場 2021：企業別、地域別、種類・用途別 The Congestive Heart Failure (CHF) Treatment Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 世界のうっ血性心不全治療薬市場 2021：企業別、地域別、種類・用途別 The Congestive Heart Failure Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の心不全遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy provides a novel strategy for targeting abnormalities in heart cells that adversely affect heart function. Market Analysis and Insights: Global Gene Therapy For Heart Failure Market The global Gene Therapy For Heart Failure market size is projected to reach US$ XX million by 2027, from …
- 世界の急性心不全（AHF）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acute Heart Failure (AHF) Therapeutics Market The global Acute Heart Failure (AHF) Therapeutics market size is projected to reach US$ 1398 million by 2026, from US$ 262.2 million in 2019, at a CAGR of 26.8% during 2021-2026. With industry-standard accuracy in ana…